FI102844B1 - Menetelmä valmistaa parannettu terapeuttisesti aktiivinen kudosplasminogeenin aktivaattori - Google Patents
Menetelmä valmistaa parannettu terapeuttisesti aktiivinen kudosplasminogeenin aktivaattoriInfo
- Publication number
- FI102844B1 FI102844B1 FI902066A FI902066A FI102844B1 FI 102844 B1 FI102844 B1 FI 102844B1 FI 902066 A FI902066 A FI 902066A FI 902066 A FI902066 A FI 902066A FI 102844 B1 FI102844 B1 FI 102844B1
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- therapeutically active
- tissue plasminogen
- improved
- active activator
- Prior art date
Links
- 102000013566 Plasminogen Human genes 0.000 title 1
- 108010051456 Plasminogen Proteins 0.000 title 1
- 239000012190 activator Substances 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 102000001938 Plasminogen Activators Human genes 0.000 abstract 1
- 108010001014 Plasminogen Activators Proteins 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 229940127126 plasminogen activator Drugs 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Graft Or Block Polymers (AREA)
- External Artificial Organs (AREA)
- Pens And Brushes (AREA)
- Fixed Capacitors And Capacitor Manufacturing Machines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27477087 | 1987-10-29 | ||
| JP27477087 | 1987-10-29 | ||
| JP32078587 | 1987-12-18 | ||
| JP32078587 | 1987-12-18 | ||
| JP7012688 | 1988-03-23 | ||
| JP7012688 | 1988-03-23 | ||
| JP18935188 | 1988-07-27 | ||
| JP18935188 | 1988-07-27 | ||
| PCT/JP1988/001098 WO1989003874A1 (fr) | 1987-10-29 | 1988-10-28 | Nouveaux composes polypeptidiques |
| JP8801098 | 1988-10-28 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI902066A0 FI902066A0 (fi) | 1990-04-25 |
| FI102844B1 true FI102844B1 (fi) | 1999-02-26 |
| FI102844B FI102844B (fi) | 1999-02-26 |
Family
ID=27465213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI902066A FI102844B (fi) | 1987-10-29 | 1990-04-25 | Menetelmä valmistaa parannettu terapeuttisesti aktiivinen kudosplasmin ogeenin aktivaattori |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US5556621A (fi) |
| JP (1) | JP2534332B2 (fi) |
| KR (1) | KR970005046B1 (fi) |
| AT (1) | ATE125294T1 (fi) |
| DE (1) | DE3854195T2 (fi) |
| DK (1) | DK104390A (fi) |
| FI (1) | FI102844B (fi) |
| HU (2) | HU217100B (fi) |
| NO (1) | NO301174B1 (fi) |
| WO (1) | WO1989003874A1 (fi) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2007364A1 (en) * | 1989-01-17 | 1990-07-17 | David J. Livingston | Gene sequences encoding modified residues situated in the protease domain of tpa |
| US6497877B1 (en) | 1997-01-29 | 2002-12-24 | University Technology Corporation | Plasminogen activator as an anti-inflammatory agent |
| KR100613531B1 (ko) | 1997-09-22 | 2006-08-16 | 도시오 미야타 | 멕신 단백질 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4753879A (en) * | 1984-08-27 | 1988-06-28 | Biogen N.V. | Modified tissue plasminogen activators |
| US5073494A (en) * | 1985-04-22 | 1991-12-17 | Genentech, Inc. | Human tissue plasminogen activator substituted at position 275 or at positions 275 and 277 |
| GR861037B (en) * | 1985-04-22 | 1986-07-16 | Genentech Inc | Novel human tissue plasminogen activator mutants |
| NZ217331A (en) * | 1985-08-26 | 1989-05-29 | Lilly Co Eli | Tissue plasminogen activator derivatives and genetically engineered product |
| WO1987003906A1 (en) * | 1985-12-20 | 1987-07-02 | The Upjohn Company | Tissue plasminogen activator (tpa) analogs |
| DK43387A (da) * | 1986-01-29 | 1987-07-30 | Beecham Group Plc | Fibrinolytisk enzym |
| AU7090887A (en) * | 1986-04-02 | 1987-10-08 | Beecham Group Plc | Plasminogen activators modified in first kringle domain |
| US4935237A (en) * | 1988-03-21 | 1990-06-19 | Genentech, Inc. | Processes for the preparation of t-PA mutants |
| JPH02504102A (ja) * | 1987-06-30 | 1990-11-29 | ジェネンテク，インコーポレイテッド | 血管障害治療のための改良法 |
| US5094953A (en) * | 1988-03-21 | 1992-03-10 | Genentech, Inc. | Human tissue plasminogen activator variants |
| US5037646A (en) * | 1988-04-29 | 1991-08-06 | Genentech, Inc. | Processes for the treatment of vascular disease |
| JP2793462B2 (ja) * | 1993-02-23 | 1998-09-03 | 山陽特殊製鋼株式会社 | 超耐食Ｎｉ基合金 |
-
1988
- 1988-10-28 JP JP63272020A patent/JP2534332B2/ja not_active Expired - Lifetime
- 1988-10-28 KR KR1019890701197A patent/KR970005046B1/ko not_active Expired - Lifetime
- 1988-10-28 WO PCT/JP1988/001098 patent/WO1989003874A1/ja not_active Ceased
- 1988-10-28 HU HU886304A patent/HU217100B/hu not_active IP Right Cessation
- 1988-10-28 DE DE3854195T patent/DE3854195T2/de not_active Expired - Lifetime
- 1988-10-28 AT AT88909384T patent/ATE125294T1/de not_active IP Right Cessation
-
1990
- 1990-04-25 FI FI902066A patent/FI102844B/fi not_active IP Right Cessation
- 1990-04-27 NO NO901920A patent/NO301174B1/no not_active IP Right Cessation
- 1990-04-27 DK DK104390A patent/DK104390A/da not_active Application Discontinuation
-
1994
- 1994-05-04 US US08/237,249 patent/US5556621A/en not_active Expired - Fee Related
-
1995
- 1995-06-30 HU HU95P/P00671P patent/HU211335A9/hu unknown
-
1996
- 1996-09-10 US US08/712,999 patent/US5739012A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HU886304D0 (en) | 1991-11-28 |
| JPH02167076A (ja) | 1990-06-27 |
| DE3854195T2 (de) | 1995-12-21 |
| FI902066A0 (fi) | 1990-04-25 |
| KR970005046B1 (ko) | 1997-04-11 |
| HU211335A9 (en) | 1995-11-28 |
| DK104390D0 (da) | 1990-04-27 |
| KR890701732A (ko) | 1989-12-21 |
| ATE125294T1 (de) | 1995-08-15 |
| FI102844B (fi) | 1999-02-26 |
| US5556621A (en) | 1996-09-17 |
| WO1989003874A1 (fr) | 1989-05-05 |
| NO901920L (no) | 1990-04-27 |
| US5739012A (en) | 1998-04-14 |
| NO301174B1 (no) | 1997-09-22 |
| JP2534332B2 (ja) | 1996-09-11 |
| DE3854195D1 (de) | 1995-08-24 |
| HUT58811A (en) | 1992-03-30 |
| NO901920D0 (no) | 1990-04-27 |
| HU217100B (hu) | 1999-11-29 |
| DK104390A (da) | 1990-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1158551A (en) | Plasminogen preparations | |
| EP0217379A3 (en) | Thrombolytic composition and a process for production thereof | |
| FI925787A0 (fi) | Proteolytiska enzymers sackarinderivatinhibitorer | |
| ES8101385A1 (es) | Un procedimiento para la preparacion de un derivado de una enzima fibrinolitica | |
| NO880774L (no) | Fremgangsmaate for fremstilling av terapeutisk akive mettede fettsyreamider. | |
| ES8800601A1 (es) | Un procedimiento para preparar una formulacion farmaceutica liofilizada de activador de plasminogeno de tejidro (t-pa) | |
| EP0278696A3 (en) | An arg-serpin human plasminogen activator inhibitor designated pai-2 | |
| DK167738B1 (da) | Fremgangsmaade til fremstilling af en oploesning med hoej specifik rumfangsaktivitet af et protein med vaevs-plasminogenaktivator(t-pa)-aktivitet, oploesning der indeholder protein med t-pa-aktivitet, og anvendelsen af oploesningen inden for human- og veterinaermedicinen | |
| SE8701921D0 (sv) | Ny farmaceutisk anvendning | |
| ATE108206T1 (de) | Gewebe-plasminogenaktivator. | |
| NO20065027L (no) | Fremgangsmate for fremstilling av en biologisk aktiv, rekombinant, human, koaguleringsfaktor VIII i et celledyrkningsmedium som tillater ekspresjon og sekresjon av polypeptidet | |
| Ahmed et al. | Biochemical characteristics of fibrolase, a fibrinolytic protease from snake venom | |
| NO954778D0 (no) | Ekspresjon av urokinase plasminogen aktivator inhibitorer | |
| Rodeheaver et al. | Proteolytic enzymes as adjuncts to antimicrobial prophylaxis of contaminated wounds | |
| GB1533205A (en) | Plasmin fractions and complexes thereof | |
| FI905919A0 (fi) | Foerfarande och material foer expression av en human plasminogenvariant. | |
| FI102844B1 (fi) | Menetelmä valmistaa parannettu terapeuttisesti aktiivinen kudosplasminogeenin aktivaattori | |
| Teng et al. | Species difference in the fibrinogenolytic effects of α-and β-fibrinogenases from Trimeresurus mucrosquamatus snake venom | |
| Sherry | Thrombolytic therapy in acute myocardial infarction: a perspective | |
| ATE103332T1 (de) | Modifizierter gewebeplasminogenaktivator. | |
| EP0326013A3 (en) | Novel proteins derived from human alpha2-plasmin inhibitor or proteins similar thereto | |
| EP0386240A4 (en) | Novel polypeptide compounds | |
| RU95115761A (ru) | 4-(n,n,n-триметиламино)-циннамоильные производные фибринолитических ферментов в качестве пролонгированного тромболитического средства и способ их получения | |
| DE3685416D1 (de) | Mittel aus einem plasmin-inhibitor und einem plasminogen-aktivator zur behandlung von thrombosen. | |
| ATE114170T1 (de) | Substitutionsvariante des gewebeplasminogenaktivators. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: YAMANOUCHI PHARMACEUTICAL CO., LTD. |